4//SEC Filing
Mack Gene 4
Accession 0001493152-25-011175
CIK 0001819411other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 8:00 PM ET
Size
5.4 KB
Accession
0001493152-25-011175
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-20+200,000→ 200,000 totalExercise: $2.29Exp: 2035-03-20→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest as to 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001737979
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 8:00 PM ET
- Size
- 5.4 KB